Jerzy M. Dziekan
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in Plasmodium falciparum Parasites.
Journal: ACS infectious diseases
Published: December 02, 2025
BioMalPar at 21 - a coming of age for malaria research and interventions.
Journal: Trends in parasitology
Published: July 13, 2025
MK-7602: a potent multi-stage dual-targeting antimalarial.
Journal: EBioMedicine
Published: June 23, 2025
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum.
Journal: Nature communications
Published: March 26, 2025
Integrated structural biology of the native malarial translation machinery and its inhibition by an antimalarial drug.
Journal: Nature structural & molecular biology
Published: February 04, 2025
Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome.
Journal: Structure (London, England : 1993)
Published: December 13, 2024
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1.
Journal: Nature communications
Published: September 30, 2024
BioMalPar XX: looking back on, and forward from, 20 years of malaria research.
Journal: Trends in parasitology
Published: June 20, 2024
Genetic validation of PfFKBP35 as an antimalarial drug target.
Journal: eLife
Published: November 07, 2023
Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV000848.
Journal: The Journal of biological chemistry
Published: September 30, 2023
Last Updated: 09/26/2026